GSMA
10.9.2019 04:02:10 CEST | Business Wire | Press release
The GSMA today announced the first speakers for the 2019 Mobile 360 Series – Digital Societies conference, which will take place 24-26 September at JW Marriott Hotel Kuala Lumpur, Malaysia. The event is supported by the Malaysian Communications and Multimedia Commission (MCMC) and also the Malaysia Convention and Exhibition Bureau (MyCEB). Host sponsor for the event is Axiata with other event sponsors including Fiberhome (Headline Sponsor), Edotco, Gigabyte, Huawei and Telepin (Industry Sponsors), as well as Arm (eSim Supporting Sponsor).
“We are excited to bring the Mobile 360 – Digital Societies event to Malaysia for the first time as mobile technology is no doubt playing a pivotal role in driving economic development in the Asia Pacific Region,” said, John Hoffman, CEO, GSMA Ltd. “This three-day event will provide a perfect platform for stakeholders to share their experiences and expand the positive impact of mobile throughout this vibrant and diverse region.”
Keynote Speakers
At the event, industry-leading speakers will shine a light on APAC innovation examining how developments in these core areas are powering digital transformation across the region. Speakers confirmed to present at Mobile 360 – Digital Societies include:
- Gobind Singh Deo, Minister of Communication and Multimedia, Malaysia
- YBrs. Encik Al-Ishsal Ishak, Chairman, Malaysian Communications and Multimedia Commission
- Sok Puthyvuth, Secretary of State, Cambodia MPTC
- Tony Fernandes, CEO, AirAsia Group
- Dr Hans Wijayasuriya, Corporate EVP and Regional CEO, South Asia, Axiata
- Loke Hwee Wong, VP, APAC, Boku
- Teddy Oetomo, CSO, Bukalapak
- Michael Patent, CEO, Culture Group
- Albern Murty, CEO, Digi Telecommunications
- Suresh Sidhu, CEO, edotco
- Wang Xiaofei, CMO, Fiberhome
- Louise Easterbrook, CFO, GSMA
- Khoo Yuen Hing, CTO, Huawei
- Masayoshi Sakai, Counsellor, Information-technology Promotion Agency, Japan
- Sohee Shin, SVP, Global Business Unit and Global Alliance Division, KT
- Gokhan Ogut, CEO, Maxis Broadband Sdn Bhd
- Maya Arvini, CCO, Qlue
- Takeshi Fukuizumi, Head of Fintech and Blockchain, Softbank
- Foong Yuh Wen, CEO and Founder, Sushivid
- Anthony Socci, President and General Manager, APAC, Synchronoss
- Vince Kadar, CEO, Telepin
- Brad Jones, CEO, Wave Money
- Kaspar Tiri, Co-Founder, Wolf 3D
- David An, CTO, ZTE Group Asia
The full conference agenda is available at https://www.mobile360series.com/digital-societies/agenda/ .
In addition to the keynotes, a series of in-depth workshops and sessions will allow a deeper dive into the industry’s most complex challenges looking at topics such as Forging Digital Societies Through Digital Platforms , Building Simple, Clear and Fast Public Services and 5G and Digitalisation . Mobile 360 – Digital Societies will examine the attributes that contribute to a successful digital society. Focusing on the digital platforms enabling new and innovative services, the event highlights the key elements that define a successful digital society including citizenship, commerce, identity, lifestyle and connectivity, and how developments in these key areas can lead to gains for society as a whole.
Women4Tech Leaders Reception
Mobile 360 – Digital Societies will host the first Women4Tech Leaders Reception in APAC on 24 September 2019 from 5:30pm-7:30pm. The event will stimulate discussion on the benefits of encouraging gender diversity in the tech industry and addressing what can be done about the current gender gap through education and public policy. It will also look at ways to promote gender diversity culture in business organisations.
Registration for Women4Tech Leaders Reception is available here: www.mobile360series.com/digital-societies/agenda/apply-to-attend-workshop/#contact
Registration for Mobile 360 – Digital Societies is now open; individuals wishing to attend should visit www.mobile360series.com/digital-societies/attend/attendee-registration/ . For further information on Mobile 360 – Digital societies, please visit: www.mobile360series.com/digital-societies/overview/ . Further information on the entire Mobile 360 Series of events is available at www.mobile360series.com/ . Follow developments and updates on Mobile 360 Series (#mobile360) on Twitter @GSMA and on Facebook www.facebook.com/Mobile360Series .
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005062/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom